Lv31
308 积分 2022-07-06 加入
ECTRIMS 2025 Late Breaking Oral Presentations
3小时前
已完结
Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy
1个月前
已完结
Single (375 mg/m2) vs. double dose of rituximab along with mycophenolate mofetil for children with steroid-dependent/frequently relapsing nephrotic syndrome: a multicentre open-label randomized controlled trial
2个月前
已完结
Obinutuzumab as a primary anti-CD20 agent in pediatric frequently relapsing and steroid-dependent nephrotic syndrome
2个月前
已完结
Outcome of Children Treated with Rituximab for Steroid-Resistant Nephrotic Syndrome: Renal Histopathology as a Response Marker
2个月前
已关闭
Association between anti-PLA2R antibody status and clinical remission in primary membranous nephropathy: a systematic review and meta-analysis
2个月前
已完结
Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis
3个月前
已完结
Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease
3个月前
已完结
Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab
3个月前
已完结
A RARE CASE OF IGA NEPHROPATHY WITH PULMONARY HEMOSIDEROSIS AND CALCIFICATION
3个月前
已关闭
皖公网安备34019202002308
